Understanding the Current Rating
The 'Sell' rating assigned to Jeevan Scientific Technology Ltd indicates a cautious stance for investors considering this stock. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the rating was revised on 13 Nov 2025, the following analysis uses the latest data available as of 06 April 2026 to offer a clear picture of the company’s present fundamentals and market behaviour.
Quality Assessment
As of 06 April 2026, the company’s quality grade remains below average. This reflects concerns about its long-term fundamental strength. Over the past five years, Jeevan Scientific Technology Ltd has experienced a steep decline in operating profits, with a compound annual growth rate (CAGR) of -169.69%. Such a negative trend signals challenges in sustaining profitability and operational efficiency. Additionally, the average Return on Equity (ROE) stands at a modest 9.56%, indicating relatively low profitability generated per unit of shareholders’ funds. These factors collectively weigh on the company’s quality score and contribute to the cautious rating.
Valuation Considerations
The valuation grade for Jeevan Scientific Technology Ltd is currently classified as risky. Despite the stock’s microcap status, it is trading at valuations that are considered elevated relative to its historical averages. The company’s negative operating profits, with an EBIT of Rs. -1.66 crore, further exacerbate concerns about its valuation. Investors should note that while the stock price has shown some resilience, the underlying financials suggest a disconnect that warrants prudence. This risky valuation profile is a significant factor behind the 'Sell' rating.
Financial Trend and Performance
Financially, the company shows a positive grade, reflecting some encouraging signs amidst the challenges. The stock has delivered strong returns over the past year, with a 53.92% gain as of 06 April 2026. The six-month return is even more impressive at 67.81%, and the year-to-date (YTD) return stands at 2.39%. However, these gains contrast sharply with the company’s profit trajectory, which has deteriorated by -378% over the past year. This divergence between stock price performance and profit decline highlights the volatility and risk inherent in the current financial trend.
Technical Analysis
From a technical perspective, the stock is graded as mildly bullish. Short-term price movements show some positive momentum, with a one-week gain of 3.13%. Nevertheless, the stock has experienced declines over the one-month (-5.89%) and three-month (-7.63%) periods, and a slight dip of -0.87% on the most recent trading day. These mixed signals suggest that while there is some buying interest, the overall technical outlook remains cautious, supporting the 'Sell' stance.
What This Rating Means for Investors
For investors, the 'Sell' rating on Jeevan Scientific Technology Ltd serves as a warning to approach the stock with caution. The combination of weak long-term fundamentals, risky valuation, and mixed technical signals suggests that the stock may face headwinds in delivering consistent returns. While recent price gains might appear attractive, the underlying financial challenges and negative profit trends imply elevated risk. Investors should carefully weigh these factors against their risk tolerance and investment horizon before considering exposure to this stock.
Sector and Market Context
Operating within the Healthcare Services sector, Jeevan Scientific Technology Ltd’s microcap status adds an additional layer of volatility and liquidity risk. The sector itself has seen varied performance, with many companies benefiting from steady demand and innovation. However, Jeevan Scientific’s financial struggles and valuation concerns differentiate it from stronger peers. This context reinforces the need for a prudent approach when evaluating this stock.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Summary of Key Metrics as of 06 April 2026
To summarise, the stock’s Mojo Score currently stands at 39.0, reflecting the 'Sell' grade assigned by MarketsMOJO. This is an improvement from the previous 'Strong Sell' rating, which had a score of 29, updated on 13 Nov 2025. Despite this relative improvement, the score remains low, signalling caution. The company’s operating profit decline, negative EBIT, and risky valuation underpin this assessment. Meanwhile, the positive financial grade and mildly bullish technical grade offer some counterbalance but are insufficient to shift the overall recommendation.
Investor Takeaway
Investors should interpret the 'Sell' rating as an indication that Jeevan Scientific Technology Ltd currently faces significant challenges that may limit its near-term upside potential. The stock’s recent price appreciation does not fully mitigate the risks posed by weak fundamentals and valuation concerns. Those holding the stock may consider reassessing their positions, while prospective investors should conduct thorough due diligence and consider alternative opportunities with stronger financial health and more favourable valuations.
Looking Ahead
Going forward, monitoring the company’s ability to stabilise operating profits and improve return metrics will be critical. Any meaningful turnaround in fundamentals could warrant a reassessment of the rating. Until then, the 'Sell' recommendation remains a prudent guide for market participants navigating the Healthcare Services microcap space.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
